SORL1 (Sortilin-related receptor) variants and mutations
SORL1 (also known as Sortilin-related receptor) is a human protein-coding gene encoding a sortilin-related receptor protein. It sorts APP and other cargo between endosomes, Golgi, and the cell surface, helping keep APP away from amyloidogenic processing compartments. Rare loss-of-function variants and common variation can substantially increase Alzheimer disease risk. This analysis covers 2,870 SORL1 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes Alzheimer disease, dementia, and early-onset autosomal dominant Alzheimer disease. Example SORL1 variants include A2E, A2G, and A2T.
Variant analysis overview
- Gene: SORL1
- Protein: Sortilin-related receptor
- UniProt accession: Q92673
- Organism: Homo sapiens
- Variants analyzed: 2870
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 2,460 unspecified-consequence records; 257 missense variants; 104 synonymous variants; 27 frameshift variants; 16 stop-gained variants; 2 in-frame deletions; 1 in-frame insertions; 1 splice-region variants; 2 substitution
- Prediction scores: 2,177 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Alzheimer disease, dementia, early-onset autosomal dominant Alzheimer disease, neurodegenerative disease, smoking initiation, liver disorder, complex hereditary spastic paraplegia, cannabis dependence, late-onset Alzheimers disease, wet macular degeneration, Microscopic hematuria, breast disorder.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 19 domains; 29 post-translational modification sites.
- Structural context: 1,942 variants have structural context.
- PTM context: 31 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SORL1 variants
Examples include A2E, A2G, A2T, A2S, A2V, A2A, T3A, T3K. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2E (p.Ala2Glu), TOPMed rs1241508891, gnomAD rs1241508891, REVEL 0.38, CADD 24.00
- A2G (p.Ala2Gly), TOPMed rs1241508891, gnomAD rs1241508891, REVEL 0.34, CADD 24.10
- A2T (p.Ala2Thr), gnomAD 11-121452335-G-A, REVEL 0.31, CADD 24.30
- A2S (p.Ala2Ser), gnomAD 11-121452335-G-T, REVEL 0.29, CADD 23.80
- A2V (p.Ala2Val), gnomAD 11-121452336-C-T, REVEL 0.39, CADD 24.20
- A2A (p.Ala2Ala), gnomAD 11-121452337-G-A, CADD 16.40
- T3A (p.Thr3Ala), gnomAD 11-121452338-A-G, REVEL 0.28, CADD 22.30
- T3K (p.Thr3Lys), gnomAD 11-121452339-C-A, REVEL 0.30, CADD 22.70
- T3I (p.Thr3Ile), gnomAD 11-121452339-C-T, REVEL 0.28, CADD 22.70
- T3T (p.Thr3Thr), gnomAD 11-121452340-A-G, CADD 16.30
- R4G (p.Arg4Gly), TOPMed rs1179499363, gnomAD rs1179499363, REVEL 0.21, CADD 22.70
- R4W (p.Arg4Trp), TOPMed rs1179499363, gnomAD rs1179499363, REVEL 0.35, CADD 24.90, Uncertain significance, not specified
- R4R (p.Arg4Arg), gnomAD 11-121452341-C-A, CADD 15.70
- R4Q (p.Arg4Gln), gnomAD 11-121452342-G-A, REVEL 0.23, CADD 22.90
- R4L (p.Arg4Leu), gnomAD 11-121452342-G-T, REVEL 0.23, CADD 23.00
- S5G (p.Ser5Gly), 1000Genomes rs566484311, TOPMed rs566484311, REVEL 0.34, CADD 24.10
- S5N (p.Ser5Asn), ExAC rs771534455, TOPMed rs771534455, gnomAD rs771534455, REVEL 0.26, CADD 24.00, Uncertain significance, not provided
- S5R (p.Ser5Arg), rs1452684273, ClinGen CA383283478, ClinVar RCV004457439, TOPMed rs1452684273, REVEL 0.33, CADD 23.50, Uncertain significance, not specified
- S5I (p.Ser5Ile), gnomAD 11-121452345-G-T, REVEL 0.26, CADD 24.40
- S5S (p.Ser5Ser), gnomAD 11-121452346-C-T, CADD 16.00
- S6T (p.Ser6Thr), rs774906532, ClinGen CA6328267, ClinVar RCV002979628, ExAC rs774906532, REVEL 0.29, CADD 22.60, Uncertain significance, not provided
- S6C (p.Ser6Cys), gnomAD 11-121452347-A-T, REVEL 0.33, CADD 26.70
- S6G (p.Ser6Gly), gnomAD 11-121452347-A-G, REVEL 0.22, CADD 22.90
- S6N (p.Ser6Asn), gnomAD 11-121452348-G-A, REVEL 0.26, CADD 22.90
- S6I (p.Ser6Ile), gnomAD 11-121452348-G-T, REVEL 0.36, CADD 23.40
- S6S (p.Ser6Ser), rs759967988, gnomAD 11-121452349-C-T, CADD 16.30
- S6R (p.Ser6Arg), gnomAD 11-121452349-C-A, REVEL 0.25, CADD 23.80
- R7S (p.Arg7Ser), ExAC rs767702195, gnomAD rs767702195, REVEL 0.24, CADD 22.90
- R7W (p.Arg7Trp), gnomAD 11-121452350-A-T, REVEL 0.40, CADD 24.20
- R7G (p.Arg7Gly), gnomAD 11-121452350-A-G, REVEL 0.29, CADD 23.30
- R7M (p.Arg7Met), gnomAD 11-121452351-G-T, REVEL 0.35, CADD 23.10
- R7T (p.Arg7Thr), gnomAD 11-121452351-G-C, REVEL 0.28, CADD 22.80
- R7R (p.Arg7Arg), gnomAD 11-121452352-G-A, CADD 16.10
- R8M (p.Arg8Met), NCI-TCGA Cosmic COSV9949, REVEL 0.39, CADD 23.20, Variant assessed as somatic; moderate impact.
- R8G (p.Arg8Gly), gnomAD 11-121452353-A-G, REVEL 0.23, CADD 23.00
- R8K (p.Arg8Lys), gnomAD 11-121452354-G-A, REVEL 0.18, CADD 22.00
- R8S (p.Arg8Ser), gnomAD 11-121452355-G-T, REVEL 0.20, CADD 22.70
- R8R (p.Arg8Arg), rs1327334637, gnomAD 11-121452355-G-A, CADD 16.10
- E9V (p.Glu9Val), Ensembl rs1860812056, REVEL 0.33, CADD 29.20
- E9S (p.Glu9Ser), gnomAD 11-121452353-AG-A, CADD 28.30
- E9K (p.Glu9Lys), gnomAD 11-121452356-G-A, REVEL 0.41, CADD 28.70
- E9* (p.Glu9Ter), gnomAD 11-121452356-G-T, CADD 36.00
- E9G (p.Glu9Gly), gnomAD 11-121452357-A-G, REVEL 0.38, CADD 31.00
- E9D (p.Glu9Asp), gnomAD 11-121452358-G-T, REVEL 0.32, CADD 24.60
- E9E (p.Glu9Glu), gnomAD 11-121452358-G-A, CADD 15.20
- S10L (p.Ser10Leu), rs775717593, ClinGen CA6328270, ClinVar RCV001994925, ExAC rs775717593, REVEL 0.23, CADD 23.10, Uncertain significance, not provided
- S10A (p.Ser10Ala), gnomAD 11-121452359-T-G, REVEL 0.30, CADD 21.70
- S10T (p.Ser10Thr), gnomAD 11-121452359-T-A, REVEL 0.32, CADD 21.10
- S10P (p.Ser10Pro), gnomAD 11-121452359-T-C, REVEL 0.22, CADD 22.70
- S10* (p.Ser10Ter), gnomAD 11-121452360-C-A, CADD 36.00
- S10S (p.Ser10Ser), gnomAD 11-121452361-G-T, CADD 15.20
- R11P (p.Arg11Pro), rs147575757, ClinGen CA6328271, ClinVar RCV002633344, ESP rs147575757, REVEL 0.31, CADD 25.20, Uncertain significance, not provided
- R11T (p.Arg11Thr), gnomAD 11-121452359-TCG-, CADD 27.50
- R11* (p.Arg11Ter), gnomAD 11-121452362-C-T, CADD 35.00
- R11R (p.Arg11Arg), gnomAD 11-121452362-C-A, CADD 15.60
- R11Q (p.Arg11Gln), gnomAD 11-121452363-G-A, REVEL 0.27, CADD 23.70
- R11L (p.Arg11Leu), gnomAD 11-121452363-G-T, REVEL 0.25, CADD 25.00
- L12I (p.Leu12Ile), gnomAD 11-121452365-C-A, REVEL 0.21, CADD 23.50
- L12F (p.Leu12Phe), gnomAD 11-121452365-C-T, REVEL 0.23, CADD 23.70
- L12P (p.Leu12Pro), gnomAD 11-121452366-T-C, REVEL 0.58, CADD 25.10
- L12L (p.Leu12Leu), gnomAD 11-121452367-C-A, CADD 14.80
- P13L (p.Pro13Leu), TOPMed rs1032527926, gnomAD rs1032527926, REVEL 0.13, CADD 21.80
- P13R (p.Pro13Arg), TOPMed rs1032527926, gnomAD rs1032527926, REVEL 0.15, CADD 19.40
- P13T (p.Pro13Thr), gnomAD 11-121452368-C-A, REVEL 0.14, CADD 20.10
- P13A (p.Pro13Ala), gnomAD 11-121452368-C-G, REVEL 0.17, CADD 18.90
- P13S (p.Pro13Ser), gnomAD 11-121452368-C-T, REVEL 0.14, CADD 20.80
- P13Q (p.Pro13Gln), gnomAD 11-121452369-C-A, REVEL 0.21, CADD 21.70
- P13P (p.Pro13Pro), rs2134756496, gnomAD 11-121452370-G-A, CADD 15.00
- F14L (p.Phe14Leu), NCI-TCGA Cosmic COSV9949, REVEL 0.20, CADD 23.00, Variant assessed as somatic; moderate impact.
- F14S (p.Phe14Ser), TOPMed rs1194166545, gnomAD rs1194166545, REVEL 0.36, CADD 23.70
- F14V (p.Phe14Val), rs2496711790, ClinGen CA383283530, ClinVar RCV004457451, Uncertain significance, not specified
- L15P (p.Leu15Pro), 1000Genomes rs1860812638, REVEL 0.63, CADD 25.60
- L15I (p.Leu15Ile), gnomAD 11-121452374-C-A, REVEL 0.27, CADD 23.20
- L15L (p.Leu15Leu), rs764189310, gnomAD 11-121452376-A-G, CADD 12.40
- F16I (p.Phe16Ile), NCI-TCGA TCGA novel, REVEL 0.23, CADD 22.30, Variant assessed as somatic; moderate impact.
- F16L (p.Phe16Leu), gnomAD 11-121452377-T-C, REVEL 0.18, MetaLR 0.32
- F16C (p.Phe16Cys), gnomAD 11-121452378-T-G, REVEL 0.26, MetaLR 0.51
- F16F (p.Phe16Phe), gnomAD 11-121452379-C-T, CADD 15.90
- T17I (p.Thr17Ile), TOPMed rs1230490942, gnomAD rs1230490942, REVEL 0.19, CADD 21.50
- T17N (p.Thr17Asn), TOPMed rs1230490942, gnomAD rs1230490942, REVEL 0.21, CADD 20.90
- T17A (p.Thr17Ala), gnomAD 11-121452380-A-G, REVEL 0.26, MetaLR 0.34
- T17P (p.Thr17Pro), gnomAD 11-121452380-A-C, REVEL 0.33, MetaLR 0.37
- T17S (p.Thr17Ser), gnomAD 11-121452381-C-G, REVEL 0.23, MetaLR 0.39
- T17T (p.Thr17Thr), gnomAD 11-121452382-C-T, CADD 16.10
- L18P (p.Leu18Pro), gnomAD rs1345706948, REVEL 0.67, CADD 28.80
- L18M (p.Leu18Met), gnomAD 11-121452383-C-A, REVEL 0.43, MetaLR 0.69
- L18L (p.Leu18Leu), rs1252464729, gnomAD 11-121452383-C-T, CADD 15.30
- L18V (p.Leu18Val), gnomAD 11-121452383-C-G, REVEL 0.41, MetaLR 0.68
- L18Q (p.Leu18Gln), gnomAD 11-121452384-T-A, REVEL 0.55, MetaLR 0.68
- L18R (p.Leu18Arg), gnomAD 11-121452384-T-G, REVEL 0.61, MetaLR 0.68
- V19I (p.Val19Ile), Ensembl rs2134756532, REVEL 0.19, CADD 18.30
- V19A (p.Val19Ala), gnomAD 11-121452387-T-C, REVEL 0.35, MetaLR 0.52
- V19V (p.Val19Val), gnomAD 11-121452388-C-G, CADD 12.70
- A20T (p.Ala20Thr), gnomAD 11-121452389-G-A, REVEL 0.23, MetaLR 0.47
- A20P (p.Ala20Pro), gnomAD 11-121452389-G-C, REVEL 0.35, MetaLR 0.54
- A20S (p.Ala20Ser), gnomAD 11-121452389-G-T, REVEL 0.23, MetaLR 0.49
- A20E (p.Ala20Glu), gnomAD 11-121452390-C-A, REVEL 0.29, MetaLR 0.48
- A20V (p.Ala20Val), gnomAD 11-121452390-C-T, REVEL 0.23, MetaLR 0.45
- A20A (p.Ala20Ala), gnomAD 11-121452391-A-G, CADD 16.70
- L21M (p.Leu21Met), gnomAD 11-121452392-C-A, REVEL 0.29, MetaLR 0.53
- L21L (p.Leu21Leu), gnomAD 11-121452392-C-T, CADD 14.90
- L21P (p.Leu21Pro), gnomAD 11-121452393-T-C, REVEL 0.66, MetaLR 0.60
- L22M (p.Leu22Met), TOPMed rs866322118, gnomAD rs866322118, REVEL 0.29, CADD 25.40
- L22V (p.Leu22Val), TOPMed rs866322118, gnomAD rs866322118, REVEL 0.28, CADD 24.90
- L22L (p.Leu22Leu), rs866322118, gnomAD 11-121452395-C-T, CADD 15.50
- L22P (p.Leu22Pro), gnomAD 11-121452396-T-C, REVEL 0.58, MetaLR 0.71
- P23L (p.Pro23Leu), rs766279573, ClinGen CA6328275, ClinVar RCV004082893, ExAC rs766279573, REVEL 0.17, CADD 20.50, Uncertain significance, not specified
- P23S (p.Pro23Ser), gnomAD 11-121452398-C-T, REVEL 0.22, MetaLR 0.42
- P23T (p.Pro23Thr), gnomAD 11-121452398-C-A, REVEL 0.20, MetaLR 0.44
- P23Q (p.Pro23Gln), gnomAD 11-121452399-C-A, REVEL 0.28, MetaLR 0.42
- P23P (p.Pro23Pro), rs368617512, gnomAD 11-121452400-G-T, CADD 14.90
- P24S (p.Pro24Ser), NCI-TCGA TCGA novel, REVEL 0.27, CADD 17.50, Variant assessed as somatic; moderate impact.
- P24R (p.Pro24Arg), gnomAD 11-121452402-C-G, REVEL 0.21, MetaLR 0.38
- P24H (p.Pro24His), gnomAD 11-121452402-C-A, REVEL 0.23, MetaLR 0.44
- P24L (p.Pro24Leu), gnomAD 11-121452402-C-T, REVEL 0.26, MetaLR 0.37
- P24P (p.Pro24Pro), rs1240295212, gnomAD 11-121452403-C-A, CADD 14.20
- G25* (p.Gly25Ter), gnomAD 11-121452404-G-T, CADD 34.00
- G25R (p.Gly25Arg), gnomAD 11-121452404-G-A, REVEL 0.32, MetaLR 0.46
- G25V (p.Gly25Val), gnomAD 11-121452405-G-T, REVEL 0.25, MetaLR 0.48
- G25E (p.Gly25Glu), gnomAD 11-121452405-G-A, REVEL 0.25, MetaLR 0.48
- G25G (p.Gly25Gly), rs2134756574, gnomAD 11-121452406-A-G, CADD 15.30
- A26P (p.Ala26Pro), rs751412092, ClinGen CA6328276, ClinVar RCV003561602, ExAC rs751412092, REVEL 0.41, CADD 23.90, Uncertain significance, not provided
- A26V (p.Ala26Val), TOPMed rs1860813876, REVEL 0.17, CADD 22.50
- A26S (p.Ala26Ser), gnomAD 11-121452407-G-T, REVEL 0.26, MetaLR 0.45
- A26T (p.Ala26Thr), gnomAD 11-121452407-G-A, REVEL 0.21, MetaLR 0.45
- A26D (p.Ala26Asp), gnomAD 11-121452408-C-A, REVEL 0.23, MetaLR 0.51
- A26A (p.Ala26Ala), gnomAD 11-121452409-T-A, CADD 15.20
- L27I (p.Leu27Ile), gnomAD 11-121452410-C-A, REVEL 0.15, MetaLR 0.47
- L27F (p.Leu27Phe), gnomAD 11-121452410-C-T, REVEL 0.15, MetaLR 0.50
- L27P (p.Leu27Pro), gnomAD 11-121452411-T-C, REVEL 0.20, MetaLR 0.52
- L27L (p.Leu27Leu), gnomAD 11-121452412-C-A, CADD 10.20
- C28W (p.Cys28Trp), 1000Genomes rs200230538, ExAC rs200230538, TOPMed rs200230538, gnomAD rs200230538, REVEL 0.20, CADD 23.90
- C28R (p.Cys28Arg), gnomAD 11-121452413-T-C, REVEL 0.24, MetaLR 0.41
- C28Y (p.Cys28Tyr), gnomAD 11-121452414-G-A, REVEL 0.20, MetaLR 0.43
- C28F (p.Cys28Phe), gnomAD 11-121452414-G-T, REVEL 0.21, MetaLR 0.45
- C28C (p.Cys28Cys), rs200230538, gnomAD 11-121452415-C-T, CADD 15.30
- C28* (p.Cys28Ter), gnomAD 11-121452415-C-A, CADD 35.00
- E29K (p.Glu29Lys), gnomAD 11-121452416-G-A, REVEL 0.12, MetaLR 0.45
- E29* (p.Glu29Ter), gnomAD 11-121452416-G-T, CADD 36.00
- E29E (p.Glu29Glu), gnomAD 11-121452418-A-G, CADD 14.30
- E29D (p.Glu29Asp), gnomAD 11-121452418-A-T, REVEL 0.10, MetaLR 0.42
- V30I (p.Val30Ile), TOPMed rs1860814064
- V30L (p.Val30Leu), TOPMed rs1860814064
- V30F (p.Val30Phe), gnomAD 11-121452419-G-T, REVEL 0.24, MetaLR 0.46
- V30V (p.Val30Val), rs559316306, gnomAD 11-121452421-C-G, CADD 14.30
- W31R (p.Trp31Arg), Ensembl rs1860814204, REVEL 0.34, CADD 21.10
- W31G (p.Trp31Gly), gnomAD 11-121452422-T-G, REVEL 0.29, MetaLR 0.43
- W31* (p.Trp31Ter), gnomAD 11-121452423-G-A, CADD 37.00
- W31L (p.Trp31Leu), gnomAD 11-121452423-G-T, REVEL 0.30, MetaLR 0.48
- W31C (p.Trp31Cys), gnomAD 11-121452424-G-T, REVEL 0.30, MetaLR 0.49
- T32K (p.Thr32Lys), ExAC rs780711159, TOPMed rs780711159, gnomAD rs780711159, REVEL 0.21, CADD 22.70
- T32S (p.Thr32Ser), gnomAD 11-121452425-A-T, REVEL 0.20, MetaLR 0.37
- T32M (p.Thr32Met), gnomAD 11-121452426-C-T, REVEL 0.23, MetaLR 0.48
- T32T (p.Thr32Thr), gnomAD 11-121452427-G-T, CADD 14.60
- Q33R (p.Gln33Arg), gnomAD rs1479326649, REVEL 0.21, CADD 5.18
- Q33* (p.Gln33Ter), gnomAD 11-121452428-C-T, CADD 34.00
- Q33E (p.Gln33Glu), gnomAD 11-121452428-C-G, REVEL 0.23, MetaLR 0.51
- Q33K (p.Gln33Lys), gnomAD 11-121452428-C-A, REVEL 0.24, MetaLR 0.47
- Q33H (p.Gln33His), gnomAD 11-121452430-G-T, REVEL 0.25, MetaLR 0.53
- Q33Q (p.Gln33Gln), gnomAD 11-121452430-G-A, CADD 13.50
- R34G (p.Arg34Gly), gnomAD 11-121452431-A-G, REVEL 0.26, MetaLR 0.49
- R34W (p.Arg34Trp), gnomAD 11-121452431-A-T, REVEL 0.25, MetaLR 0.55
- R34M (p.Arg34Met), gnomAD 11-121452432-G-T, REVEL 0.32, MetaLR 0.51
- R34S (p.Arg34Ser), gnomAD 11-121452433-G-T, REVEL 0.29, MetaLR 0.39
- R34R (p.Arg34Arg), rs747778796, gnomAD 11-121452433-G-A, CADD 12.80
- L35R (p.Leu35Arg), rs755601132, ClinGen CA6328280, ClinVar RCV002613225, ExAC rs755601132, REVEL 0.24, CADD 24.30, Uncertain significance, not provided
- L35L (p.Leu35Leu), gnomAD 11-121452434-C-T, CADD 14.50
- L35M (p.Leu35Met), gnomAD 11-121452434-C-A, REVEL 0.20, MetaLR 0.59
- L35P (p.Leu35Pro), gnomAD 11-121452435-T-C, REVEL 0.42, MetaLR 0.52
- H36Y (p.His36Tyr), rs2496712086, ClinGen CA383283663, NCI-TCGA Cosmic COSV9949, ClinVar RCV004109495, REVEL 0.21, CADD 18.30, Uncertain significance, not specified
- H36D (p.His36Asp), gnomAD 11-121452437-C-G, REVEL 0.22, MetaLR 0.62
- H36N (p.His36Asn), gnomAD 11-121452437-C-A, REVEL 0.24, MetaLR 0.62
- H36R (p.His36Arg), gnomAD 11-121452438-A-G, REVEL 0.28, MetaLR 0.49
- H36Q (p.His36Gln), gnomAD 11-121452439-C-A, REVEL 0.26, MetaLR 0.56
- H36H (p.His36His), gnomAD 11-121452439-C-T, CADD 12.60
- G37D (p.Gly37Asp), gnomAD rs1860814619, REVEL 0.18, CADD 22.30
- G37C (p.Gly37Cys), gnomAD 11-121452440-G-T, REVEL 0.41, MetaLR 0.70
- G37S (p.Gly37Ser), gnomAD 11-121452440-G-A, REVEL 0.33, MetaLR 0.52
- G37R (p.Gly37Arg), gnomAD 11-121452440-G-C, REVEL 0.33, MetaLR 0.65
- G37V (p.Gly37Val), gnomAD 11-121452441-G-T, REVEL 0.28, MetaLR 0.51
Public SORL1 analysis runs
- SORL1 analysis run — SORL1 (2,870 variants) — completed 2026-08-21